Abeona Therapeutics Inc.
ABEO
|
$7.6
0.93%
0.92%
390K
|
Health Technology
(0.0% 1d) (0.0% 1m) (143.7% 1y) (0.0% 2d) (0.0% 3d) (-1.4% 7d) (12.54% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 207,898,281
http://www.abeonatherapeutics.com
Sec Filling | Patents | 88 employees
(US) Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.
skin gene therapies
add to watch list Paper trade email alert is off
Press-releases
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-01 (Crawled : 12:30) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -1.16%
H: 7.48%
C: 6.93%
nasdaq grants therapeutics employee
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 1, 2024
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -1.16%
H: 7.48%
C: 6.93%
nasdaq grants therapeutics employee
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -7.65%
H: 0.0%
C: 0.0%
fda year therapeutics financial results
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-05 (Crawled : 12:30) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -4.86%
H: 0.0%
C: 0.0%
nasdaq grants therapeutics employee
Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
RLMD | $4.0 -6.98% -7.5% 150K
|
Health Technology
|
| O: 1.11%
H: 1.47%
C: -6.04%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
pharma financial
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-01 (Crawled : 21:00) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -2.86%
H: 5.42%
C: 4.25%
nasdaq grants therapeutics employee
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
Published: 2024-02-01 (Crawled : 12:30) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
license update application therapeutics
Abeona Therapeutics Announces $50 Million Credit Facility
Published: 2024-01-08 (Crawled : 12:30) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -3.19%
H: 4.37%
C: 4.1%
million therapeutics
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-15 (Crawled : 12:30) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
nasdaq grants therapeutics employee
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published: 2023-12-12 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.56%
H: 0.51%
C: 0.51%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -5.13%
H: 5.41%
C: 3.46%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.45%
H: 0.75%
C: 0.46%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.18%
H: 0.43%
C: 0.25%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: 5.62%
H: 3.72%
C: -4.26%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.59%
H: 1.35%
C: 0.6%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 1.83%
H: 0.04%
C: -1.13%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -0.46%
H: 5.56%
C: -1.12%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 0.65%
H: 2.59%
C: 0.86%
america therapy growth market
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001493152-24-005208 | 4 | 2024-02-07 | 2024-02-06 | Buy | P | 20000 | 528260 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10